Oxadiazoanthracene compounds for the treatment of diabetes

Details for Australian Patent Application No. 2009221722 (hide)

Owner TransTech Pharma, Inc.

Inventors Davis, Stephen Thomas; Behme, Christopher; Yokum, Thomas Scott; Guzel, Mustafa; Polisetti, Dharma Rao; Santhosh, Kalpathy; Mjalli, Adnan M. M.

Agent Shelston IP

Pub. Number AU-A-2009221722

PCT Pub. Number WO2009/111700

Priority 61/034,599 07.03.08 US

Filing date 6 March 2009

Wipo publication date 11 September 2009

International Classifications

A01N 35/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical

A61K 31/12 (2006.01) - Ketones

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111700 Priority application(s): WO2009/111700

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221728-Polypeptides having beta-glucosidase activity and polynucleotides encoding same

2009221720-Improved anticancer treatments